Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1989 Apr;102(2):205–214. doi: 10.1017/s0950268800029873

Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

C Wolz 1, G Kiosz 1, J W Ogle 1, M L Vasil 1, U Schaad 1, K Botzenhart 1, G Döring 1
PMCID: PMC2249438  PMID: 2495226

Abstract

To investigate cross-colonization with and persistence of Pseudomonas aeruginosa in cystic fibrosis (CF), 181 isolates from 76 CF patients were typed using a P. aeruginosa-specific DNA probe. Whereas sibling pairs predominantly harboured genotypically identical P. aeruginosa strains, all of the other patients harboured different strains. Seventy-nine per cent (22/31) of the infected CF patients harboured the same strains at the beginning and the end of a summer camp. A change of strains was seen in 10% (3/31) of the patients at the end of the camp. Forty-six per cent (6/13) of the patients who were apparently initially uninfected, acquired P. aeruginosa by the end of the period. Genotyping proved that strain change or acquisition was due to cross-colonization in four of nine cases. Very little P. aeruginosa was isolated from the inanimate environment. Persistence of P. aeruginosa after a temporary loss due to antibiotic therapy was seen in 12/16 paired patient strains before and after antibiotic therapy. Thus, suppression followed a flare-up seemed to occur in these patients rather than eradication and a new infection. When 35 patients were followed over a period of 6 months, 7 (20%) changed the strain in their sputum. Only one of 43 patients harboured two different P. aeruginosa strains simultaneously over a long period.

Full text

PDF
207

Images in this article

209Fig. 2
on p.209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergan T., Hoiby N. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis. Acta Pathol Microbiol Scand Suppl. 1975 Dec;83(6):553–560. [PubMed] [Google Scholar]
  2. Döring G., Goldstein W., Röll A., Schiøtz P. O., Høiby N., Botzenhart K. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun. 1985 Sep;49(3):557–562. doi: 10.1128/iai.49.3.557-562.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Döring G., Høiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun. 1983 Oct;42(1):197–201. doi: 10.1128/iai.42.1.197-201.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Döring G., Obernesser H. J., Botzenhart K., Flehmig B., Høiby N., Hofmann A. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis. 1983 Apr;147(4):744–750. doi: 10.1093/infdis/147.4.744. [DOI] [PubMed] [Google Scholar]
  5. Fonseca K., MacDougall J., Pitt T. L. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. J Clin Pathol. 1986 Feb;39(2):220–222. doi: 10.1136/jcp.39.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hardy K. A., McGowan K. L., Fisher M. C., Schidlow D. V. Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr. 1986 Jul;109(1):51–54. doi: 10.1016/s0022-3476(86)80571-6. [DOI] [PubMed] [Google Scholar]
  7. Høiby N., Rosendal K. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol Microbiol Scand B. 1980 Jun;88(3):125–131. doi: 10.1111/j.1699-0463.1980.tb02617.x. [DOI] [PubMed] [Google Scholar]
  8. Kelly N. M., Fitzgerald M. X., Tempany E., O'Boyle C., Falkiner F. R., Keane C. T. Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet. 1982 Sep 25;2(8300):688–690. doi: 10.1016/s0140-6736(82)90714-0. [DOI] [PubMed] [Google Scholar]
  9. Laraya-Cuasay L. R., Cundy K. R., Huang N. N. Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families. J Pediatr. 1976 Jul;89(1):23–26. doi: 10.1016/s0022-3476(76)80920-1. [DOI] [PubMed] [Google Scholar]
  10. Ogle J. W., Janda J. M., Woods D. E., Vasil M. L. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis. 1987 Jan;155(1):119–126. doi: 10.1093/infdis/155.1.119. [DOI] [PubMed] [Google Scholar]
  11. Pedersen S. S., Koch C., Høiby N., Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 1986 Apr;17(4):505–516. doi: 10.1093/jac/17.4.505. [DOI] [PubMed] [Google Scholar]
  12. Pitt T. L. Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):238–247. doi: 10.1007/BF01963095. [DOI] [PubMed] [Google Scholar]
  13. Schaad U. B., Wedgwood-Krucko J., Suter S., Kraemer R. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr. 1987 Oct;111(4):599–605. doi: 10.1016/s0022-3476(87)80130-0. [DOI] [PubMed] [Google Scholar]
  14. Seale T. W., Thirkill H., Tarpay M., Flux M., Rennert O. M. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients. J Clin Microbiol. 1979 Jan;9(1):72–78. doi: 10.1128/jcm.9.1.72-78.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  16. Speert D. P., Campbell M. E. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect. 1987 Jan;9(1):11–21. doi: 10.1016/0195-6701(87)90089-2. [DOI] [PubMed] [Google Scholar]
  17. Speert D. P., Lawton D., Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J Pediatr. 1982 Aug;101(2):227–228. doi: 10.1016/s0022-3476(82)80127-3. [DOI] [PubMed] [Google Scholar]
  18. Thomassen M. J., Demko C. A., Doershuk C. F. Cystic fibrosis: a review of pulmonary infections and interventions. Pediatr Pulmonol. 1987 Sep-Oct;3(5):334–351. doi: 10.1002/ppul.1950030510. [DOI] [PubMed] [Google Scholar]
  19. Thomassen M. J., Demko C. A., Doershuk C. F., Root J. M. Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol. 1985 Jan-Feb;1(1):40–45. doi: 10.1002/ppul.1950010110. [DOI] [PubMed] [Google Scholar]
  20. VOGT D. Uber den gegenwärtigen Stand der Akzeleration in Bayern. Arch Kinderheilkd. 1959;159(2):141–156. [PubMed] [Google Scholar]
  21. Vasil M. L., Chamberlain C., Grant C. C. Molecular studies of Pseudomonas exotoxin A gene. Infect Immun. 1986 May;52(2):538–548. doi: 10.1128/iai.52.2.538-548.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wood R. E., Boat T. F., Doershuk C. F. Cystic fibrosis. Am Rev Respir Dis. 1976 Jun;113(6):833–878. doi: 10.1164/arrd.1976.113.6.833. [DOI] [PubMed] [Google Scholar]
  23. Zierdt C. H., Williams R. L. Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol. 1975 Jun;1(6):521–526. doi: 10.1128/jcm.1.6.521-526.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zimakoff J., Høiby N., Rosendal K., Guilbert J. P. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J Hosp Infect. 1983 Mar;4(1):31–40. doi: 10.1016/0195-6701(83)90062-2. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES